413 related articles for article (PubMed ID: 25485735)
21. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
[TBL] [Abstract][Full Text] [Related]
22. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.
McAdam-Marx C; McGarry LJ; Hane CA; Biskupiak J; Deniz B; Brixner DI
J Manag Care Pharm; 2011 Sep; 17(7):531-46. PubMed ID: 21870894
[TBL] [Abstract][Full Text] [Related]
23. [Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].
Kryczka W; Chrapek M; Paluch K; Zarebska-Michaluk D; Urbaniak A
Pol Arch Med Wewn; 2003 Aug; 110(2):869-75. PubMed ID: 14682226
[TBL] [Abstract][Full Text] [Related]
24. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
25. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
[TBL] [Abstract][Full Text] [Related]
26. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
Ryder SD; Irving WL; Jones DA; Neal KR; Underwood JC;
Gut; 2004 Mar; 53(3):451-5. PubMed ID: 14960533
[TBL] [Abstract][Full Text] [Related]
27. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
28. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
29. Projecting future complications of chronic hepatitis C in the United States.
Davis GL; Albright JE; Cook SF; Rosenberg DM
Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
[TBL] [Abstract][Full Text] [Related]
30. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
[TBL] [Abstract][Full Text] [Related]
31. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.
Anadol E; Schierwagen R; Elfimova N; Tack K; Schwarze-Zander C; Eischeid H; Noetel A; Boesecke C; Jansen C; Dold L; Wasmuth JC; Strassburg CP; Spengler U; Rockstroh JK; Odenthal M; Trebicka J
Hepatology; 2015 Jan; 61(1):46-55. PubMed ID: 25125218
[TBL] [Abstract][Full Text] [Related]
33. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
Livingston SE; Deubner H; Bruden DL; McMahon BJ; Homan CE; Townshend-Bulson LJ; Bruce MG; Hennessy TW; Williams JL; Gretch DR
Can J Gastroenterol; 2010 Jul; 24(7):445-51. PubMed ID: 20652161
[TBL] [Abstract][Full Text] [Related]
35. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
36. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
van der Meer AJ; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Heathcote EJ; Manns MP; Kuske L; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL
JAMA; 2012 Dec; 308(24):2584-93. PubMed ID: 23268517
[TBL] [Abstract][Full Text] [Related]
37. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.
Khan KN; Yatsuhashi H
Alcohol Alcohol; 2000; 35(3):286-95. PubMed ID: 10869250
[TBL] [Abstract][Full Text] [Related]
38. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
Kirk GD; Mehta SH; Astemborski J; Galai N; Washington J; Higgins Y; Balagopal A; Thomas DL
Ann Intern Med; 2013 May; 158(9):658-66. PubMed ID: 23440167
[TBL] [Abstract][Full Text] [Related]
39. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
40. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
